Dobutamine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dobutamine" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

399^th place

333^rd place

3^rd place

6^th place

archive.org

Parker K, Brunton L, Goodman LS, Blumenthal D, Buxton I (2008). Goodman & Gilman's manual of pharmacology and therapeutics. McGraw-Hill Medical. pp. 159. ISBN 978-0-07-144343-2.

Wilson WC, Grande CM, Hoyt DB (2007). Trauma: Critical Care. CRC Press. p. 302. ISBN 978-1-4200-1684-0.

Gentile P, Marini C, Ammirati E, Perna E, Saponara G, Garascia A, et al. (October 2021). "Long-term administration of intravenous inotropes in advanced heart failure". ESC Heart Failure. 8 (5): 4322–4327. doi:10.1002/ehf2.13394. PMC 8497373. PMID 34191408.
Tariq S, Aronow WS (December 2015). "Use of Inotropic Agents in Treatment of Systolic Heart Failure". International Journal of Molecular Sciences. 16 (12): 29060–29068. doi:10.3390/ijms161226147. PMC 4691094. PMID 26690127.
Tibayan FA, Chesnutt AN, Folkesson HG, Eandi J, Matthay MA (August 1997). "Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation". American Journal of Respiratory and Critical Care Medicine. 156 (2 Pt 1): 438–444. doi:10.1164/ajrccm.156.2.9609141. PMID 9279221.
Tuttle RR, Mills J (January 1975). "Dobutamine: development of a new catecholamine to selectively increase cardiac contractility". Circulation Research. 36 (1): 185–196. doi:10.1161/01.RES.36.1.185. PMID 234805.

"Dobutamine (Dobutrex) Use During Pregnancy". Drugs.com. 18 March 2020. Retrieved 17 May 2020.
"Dobutamine Hydrochloride Monograph for Professionals". Drugs.com. AHFS. Retrieved 11 January 2019.

Gentile P, Marini C, Ammirati E, Perna E, Saponara G, Garascia A, et al. (October 2021). "Long-term administration of intravenous inotropes in advanced heart failure". ESC Heart Failure. 8 (5): 4322–4327. doi:10.1002/ehf2.13394. PMC 8497373. PMID 34191408.
Tariq S, Aronow WS (December 2015). "Use of Inotropic Agents in Treatment of Systolic Heart Failure". International Journal of Molecular Sciences. 16 (12): 29060–29068. doi:10.3390/ijms161226147. PMC 4691094. PMID 26690127.
Tibayan FA, Chesnutt AN, Folkesson HG, Eandi J, Matthay MA (August 1997). "Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation". American Journal of Respiratory and Critical Care Medicine. 156 (2 Pt 1): 438–444. doi:10.1164/ajrccm.156.2.9609141. PMID 9279221.
Tuttle RR, Mills J (January 1975). "Dobutamine: development of a new catecholamine to selectively increase cardiac contractility". Circulation Research. 36 (1): 185–196. doi:10.1161/01.RES.36.1.185. PMID 234805.

Gentile P, Marini C, Ammirati E, Perna E, Saponara G, Garascia A, et al. (October 2021). "Long-term administration of intravenous inotropes in advanced heart failure". ESC Heart Failure. 8 (5): 4322–4327. doi:10.1002/ehf2.13394. PMC 8497373. PMID 34191408.
Tariq S, Aronow WS (December 2015). "Use of Inotropic Agents in Treatment of Systolic Heart Failure". International Journal of Molecular Sciences. 16 (12): 29060–29068. doi:10.3390/ijms161226147. PMC 4691094. PMID 26690127.